Hypertriglyceridemia is Often Under Recognized As an Aetiologic Risk Factor for Acute Pancreatitis: A Population-based Cohort Study
Overview
Gastroenterology
Authors
Affiliations
Background: Severe hypertriglyceridemia (HTG) is a well-known risk factor for acute pancreatitis, but updated population-based estimates on incidence of HTG-associated pancreatitis are lacking.
Methods: We identified all individuals with severe HTG (triglyceride level >10 mmol/L [886 mg/dL]) in a population-based sample from 2008 to 2019 and linked these with Danish nationwide health-registers to identify patients with acute pancreatitis. Pancreatitis cases were subsequently confirmed by a detailed medical chart review. Crude and standardized incidence rates were estimated and studied in relation to age, gender and time-period. In addition, aetiological classification designated during index hospitalization, severity and follow-up of individuals with HTG-associated pancreatitis were studied.
Results: Among 2146 individuals with severe HTG during the observation period, 75 were diagnosed with acute pancreatitis (3.5%). The mean incidence rate of HTG-associated pancreatitis was 1.4 (95% CI, 1.1-1.7) per 100,000 person years for the total population, for women it was 0.7 (95% CI, 0.5-1.1) and for men 2.0 (95% CI, 1.5-2.6) per 100,000 person-years. The mean incidence rate increased from 0.7 to 1.7 per 100,000 person-years from 2008 to 2019 (p = 0.01). The highest incidence rate of HTG-associated pancreatitis was observed for men in the age group 50-59 years. An elevated triglyceride level was recognized as aetiological risk factor in 35% of patients during index hospitalization.
Conclusions: Only a fraction of patients with severe HTG are hospitalized for acute pancreatitis, but the incidence is increasing. In more than half of patients elevated triglycerides is not recognized as a risk factor for acute pancreatitis during index hospitalization.
Huang Y, Qiu M, Pan S, Zhou Y, Huang X, Jin Y Ann Med. 2024; 57(1):2442073.
PMID: 39699078 PMC: 11660302. DOI: 10.1080/07853890.2024.2442073.
Zhou J, Wang Z, Liu Q, Cao L, de-Madaria E, Capurso G BMC Med. 2024; 22(1):535.
PMID: 39548430 PMC: 11566486. DOI: 10.1186/s12916-024-03755-8.
Reiche W, Walters R J Racial Ethn Health Disparities. 2024; .
PMID: 39251499 DOI: 10.1007/s40615-024-02171-1.
Two successful pregnancies -in patients taking Volanesorsen for familial chylomicronemia syndrome.
Wanninayake S, Ochoa-Ferraro A, Patel K, Ramachandran R, Wierzbicki A, Dawson C JIMD Rep. 2024; 65(4):249-254.
PMID: 38974616 PMC: 11224504. DOI: 10.1002/jmd2.12435.
Zhang H, Su Z, Feng Y, Li S, Xie B World J Clin Cases. 2024; 12(11):1918-1928.
PMID: 38660541 PMC: 11036510. DOI: 10.12998/wjcc.v12.i11.1918.